Kromek Group (LON:KMK – Get Free Report) issued its earnings results on Monday. The company reported GBX 0.40 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Kromek Group had a return on equity of 1.32% and a net margin of 2.70%.
Kromek Group Stock Down 2.6%
Shares of Kromek Group stock traded down GBX 0.18 on Tuesday, hitting GBX 6.70. The company had a trading volume of 2,713,135 shares, compared to its average volume of 1,947,306. The company has a debt-to-equity ratio of 17.19, a quick ratio of 0.82 and a current ratio of 2.39. The stock has a market capitalization of £43.91 million, a price-to-earnings ratio of 3.35 and a beta of 1.34. The stock has a 50 day moving average of GBX 8.03 and a 200-day moving average of GBX 9.15. Kromek Group has a 1 year low of GBX 5.13 and a 1 year high of GBX 13.
Insider Transactions at Kromek Group
In other news, insider Rakesh Sharma acquired 145,454 shares of Kromek Group stock in a transaction on Tuesday, September 15th. The stock was acquired at an average cost of GBX 7 per share, with a total value of £10,181.78. Over the last ninety days, insiders have bought 418,959 shares of company stock valued at $3,062,126. Corporate insiders own 8.30% of the company’s stock.
About Kromek Group
Our goal is a simple one, to make the world a safer and healthier place; we’re striving to support the global effort in Radiological and Biological Threat detection and management, as well enhance the quality of Advanced Imaging for the medical and industrial sectors, through our evolved, innovative and field proven products and solutions.
Kromek Group designs, develops, manufactures and markets both hardware and software of CZT solid-state Radiation Detectors and Scintillation Radiation Detector components and products to OEM, Civil Nuclear, Security Sectors and Government Bodies across the globe.
Featured Articles
- Five stocks we like better than Kromek Group
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Kromek Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kromek Group and related companies with MarketBeat.com's FREE daily email newsletter.
